Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Lung Cancer

Free Subscription 28.09.2026 3 Ann Thorac Surg 1 Arch Bronconeumol 1 BMC Cancer 1 Cancer 2 Cancer Sci 2 Int J Cancer 2 Int J Radiat Oncol Biol Phys 2 J Thorac Cardiovasc Surg 1 J Thorac Oncol 5 Lung Cancer 1 N Engl J Med 1 Nat Med 1 Oncogene 1 Oncologist 1 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Thorac Surg

1. SEYOUM N, Eaton D Jr, Ghani A, Rossetti N, et al
   Outcomes After Incomplete N1 Versus N2 Nodal Evaluation in Stage I Non-Small Cell Lung Cancer.
   Ann Thorac Surg. 2026 Sep 22:S0003-4975(26)00957.
   PubMed         Abstract available
   
   
2. FU F, Jin Y, Deng C, Cao H, et al
   Diagnosis of the Novel IASLC Grading System Using Intraoperative Frozen Section (ECTOP-1014): A Prospective, Multicenter Clinical Trial.
   Ann Thorac Surg. 2026;122:939-946.
   PubMed         Abstract available
   
   
3. POHLMAN A, Marten AD, Coughlin JM, Lubawski J, et al
   Impact of Neoadjuvant Therapy, Tumor Size, and Surgical Approach on Conversion to Open Thoracotomy During Lobectomy.
   Ann Thorac Surg. 2026;122:948-956.
   PubMed         Abstract available
   
   

   
   Arch Bronconeumol

4. HUEBNER A
   Tumor Heterogeneity and Metastatic Potential in Lung Cancer: How Early Can a Tumor Become Metastatic?
   Arch Bronconeumol. 2026 Sep 24:S0300-2896(26)00330.
   PubMed        
   
   

   
   BMC Cancer

5. HASIMOGLU GURUN K, Cikladilmez F, Demirag G, Yilmaz B, et al
   Single-session agreement of ChatGPT and Gemini treatment recommendations with multidisciplinary tumor board decisions in thoracic oncology.
   BMC Cancer. 2026;26:1133.
   PubMed         Abstract available
   
   

   
   Cancer

6. HENLEY SJ, Siegel DA, Firth AU, Siegel RL, et al
   Annual Report to the Nation on the Status of Cancer, featuring 21st century progress against lung cancer.
   Cancer. 2026;132:e70577.
   PubMed         Abstract available
   
   

   
   Cancer Sci

7. MATSUNAGA T, Wakai K, Tamura T, Nagayoshi M, et al
   Triangulating Evidence on Serum Uric Acid and Cancer Risk: Consistent Inverse Associations With Lung Cancer.
   Cancer Sci. 2026 Sep 20:10.1111/cas.70540. doi: 10.1111/cas.70540.
   PubMed         Abstract available
   
   
8. MASUI Y, Yoshida T, Yamaguchi Y, Miyakoshi J, et al
   Comprehensive Genomic Profiling Beyond Driver Testing in Non-Squamous Non-Small Cell Lung Cancer With Known Drivers.
   Cancer Sci. 2026 Sep 22:10.1111/cas.70538. doi: 10.1111/cas.70538.
   PubMed         Abstract available
   
   

   
   Int J Cancer

9. NIKOLAEVA M, Bellomo J, Gonel M, Stumpo V, et al
   Clinical Implementation and Oncological Relevance of Molecular Profiling in Brain Metastases Patients-A Multicenter Retrospective Cohort Study.
   Int J Cancer. 2026 Jun 18. doi: 10.1002/ijc.70611.
   PubMed         Abstract available
   
   
10. BOSETTI C, Visser O, Van Eycken L, Pettersson D, et al
    Availability of Stage Information From Cancer Registries Providing Data to the European Cancer Information System for Six Selected Cancers.
    Int J Cancer. 2026;159:2540-2551.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

11. HOFFMANN L, Paradis KC
    Special Medical Physics Management of Type 1 Reirradiation of Recurrent Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2026;126:620-621.
    PubMed        
    
    
12. GAN GN, Reddy K
    Snap To It! Managing Locoregional Lung Cancer Recurrence With Re-irradiation.
    Int J Radiat Oncol Biol Phys. 2026;126:616-617.
    PubMed        
    
    

    
    J Thorac Cardiovasc Surg

13. KIDANE B, Bott M, Spicer J, Backhus L, et al
    2026 Revised Recommendations of The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2026 Sep 25:S0022-5223(26)01243.
    PubMed         Abstract available
    
    
14. EBERST G, Henriques J, Thomas PA, Giroux-Leprieur E, et al
    Impact of CT scan-based vs. minimal follow-up on patient-reported outcomes after surgery for non-small cell lung cancer in IFCT-0302 phase III trial.
    J Thorac Cardiovasc Surg. 2026 Sep 22:S0022-5223(26)01307.
    PubMed         Abstract available
    
    

    
    J Thorac Oncol

15. BARBI J, Patnaik SK, Yendamuri S
    A Response to the Letter to the Editor: "Central Adiposity, Confounding Medications, and the Reinterpretation of the "Obesity Paradox" in Lung Cancer Risk".
    J Thorac Oncol. 2026 Sep 25:104171. doi: 10.1016/j.jtho.2026.104171.
    PubMed        
    
    

    
    Lung Cancer

16. YAMADA A, Salman HA, Tanaka K, Kinoshita Y, et al
    Change in the incidence of medication-related osteonecrosis of the jaw in lung cancer patients receiving bone modifying agents with immune checkpoint inhibitors.
    Lung Cancer. 2026;221:109626.
    PubMed        
    
    
17. DE GUNTEN A, Mogenet A, Bronstein A, Pollien E, et al
    Outcomes of long-term responders to immunotherapy in the treatment of advanced non-small cell lung cancer (NSCLC). A retrospective regional study.
    Lung Cancer. 2026;221:109627.
    PubMed         Abstract available
    
    
18. FERNANDEZ-BUSSY S, Murillo-Torres RM, Rojas-Zapata TA, Yu Lee-Mateus A, et al
    Robotic-assisted bronchoscopic biopsy and EBUS-TBNA in lung cancer: An outcome comparison between clinical and pathological staging.
    Lung Cancer. 2026;221:109630.
    PubMed         Abstract available
    
    
19. LEDDA RE, Sabia F, Beck KS, Milanese G, et al
    Long-term efficacy and adherence of a lung cancer screening strategy with extended LDCT intervals: Results from the BioMILD trial.
    Lung Cancer. 2026;221:109629.
    PubMed         Abstract available
    
    
20. SUMI T, Nagano Y, Honjo O, Ishikawa T, et al
    Time-dependent impact of programmed death-ligand 1 expression on early progression and long-term response to first-line osimertinib in epidermal growth factor receptor-mutant non-small cell lung cancer.
    Lung Cancer. 2026;221:109632.
    PubMed         Abstract available
    
    

    
    N Engl J Med

21. NEAMTIU L, Callister MEJ, Crosbie P, Lam S, et al
    IARC Perspective on Lung Cancer Screening.
    N Engl J Med. 2026 Sep 24. doi: 10.1056/NEJMsb2608211.
    PubMed        
    
    

    
    Nat Med

22. O'LEARY K
    An antibody-drug conjugate for small-cell lung cancer.
    Nat Med. 2026 Sep 23. doi: 10.1038/d41591-026-00047.
    PubMed        
    
    

    
    Oncogene

23. LI T, Li X, Zou Y, Wong TKF, et al
    Phylogenetic and phylodynamic approaches to understanding the evolution of non-small cell lung cancer using single-cell sequencing.
    Oncogene. 2026 Sep 24. doi: 10.1038/s41388-026-03997.
    PubMed         Abstract available
    
    

    
    Oncologist

24. CATLI MM, Onder AH
    Cost, context, and confounding: rethinking real-world data generation and interpretation in advanced NSCLC.
    Oncologist. 2026;31:oyag106.
    PubMed         Abstract available
    
    

    
    Thorax

25. YANG L, Kang N, Xue T, Wang N, et al
    PM(2.5), O(3) and survival gains from China's clean air actions among patients with lung cancer: a 20-year registry-based cohort study in Beijing.
    Thorax. 2026 Sep 23:thorax-2026-225199. doi: 10.1136/thorax-2026-225199.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum